This interview is part of a series of conversations MarketWatch is conducting with some of the leading voices in the U.S. on the COVID-19 pandemic.
MarketWatch: What are some things you’d like Americans to better understand about how we develop drugs and vaccines in the U.S.? MarketWatch: Just to clarify: the EUA means that any COVID patient who fits that profile or the indication can now receive plasma. So there would be no need to enroll in a trial?
But we’ve got a long way to go. In every step of this pandemic, our country has underestimated the tenacity of this virus and overestimated our ability to contain it. As a result, we’re into month eight of the “first wave” whereas so many countries around the world got through this in two and a half to three months. We opened up too early. We let down our guard. There’s not been a coordinated national strategy. Every state is pursuing their own strategy.
— Dr. Howard Koh Koh: We’ve never had a national strategy. It’s always been 50 states.
It's not going to happen in the United States. British Columbia had the lowest cases rate until the 'bubbles' began to burst. Now, despite heroic medical efforts and testing, the COVID is re-surging, mainly through domestic and international air flights. It's a plague, people.😱
Is WeWork done for?
Only under BIDEN
Hate to tell you it’s coming back in other countries.